Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Asami, Osaka

Naohito Asami, Osaka JP

Patent application numberDescriptionPublished
20100176110VEHICLE HEATING SYSTEM - When a seat heater and a planar electric heater on a surface of an interior member are used in parallel, the seat heater and the planar electric heater cannot be heated sufficiently due to a limitation on an electric capacity of a vehicle, and in particular, in a vehicle having good engine efficiency, heating of an interior of a passenger compartment by air conditioning utilizing hot air generated by heat expelled from an engine is not sufficient, whereby there sometimes occurs a situation where occupants feel cold. A heating device 07-15-2010

Sumio Asami, Osaka JP

Patent application numberDescriptionPublished
20080207747Lipase Inhibitors - The present invention provides lipase inhibitors containing flavan-3-ol monomers or acylates thereof derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the present invention provides lipase inhibitors containing at least one of flavan-3-ol monomers represented by the formula:08-28-2008
20080275258Epigallocatechin Dimers or Trimers Having Lipase Inhibitory Activity and/or Antioxidant Activity - It is intended to provide a lipase activity inhibitor which shows a high inhibitory activity on pancreatic lipase, regulates the absorption of fat from meals and/or contributes to the regulation or prevention of obesity, a food and a drink containing the same, and a tea-origin lipase inhibitor being highly preferable and not worsening taste. It is also intended to provide a method of producing the lipase inhibitor. It is further intended to provide antioxidative agent. To overcome these problems, an epigallocatechin dimer (oolong homo bis flavans) or trimer is added to foods or drinks. Thus, the absorption of fat from meals can be regulated and an antioxidative effect can be obtained. The above compounds can be produced by reacting epigallocatechin gallate with formaldehyde in the presence of an acid.11-06-2008
20080306284Lipase Inhibitors - The present invention provides lipase inhibitors containing dimers having an epigallocatechin gallate (EGCG) unit derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the present invention provides lipase inhibitors containing at least one of proanthocyanidins represented by the formula:12-11-2008
20080317821Lipase Inhibitors - The present invention provides lipase inhibitors containing dimers of flavan-3-ols derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the present invention provides lipase inhibitors containing at least one of assamicains represented by the formula:12-25-2008
20090042812Lipase inhibitors - The present invention provides lipase inhibitory agents comprising a gallotannin or ellagitannin component(s) isolated from teas or Tellima grandiflora as well as foods and beverages and medicines containing said inhibitory agents.02-12-2009
20100144866ANTI-FATIGUE AGENTS AND ORAL COMPOSITIONS CONTAINING ANDROGRAPHOLIDE AS ACTIVE INGREDIENT - Disclosed is a composition which is safe for a human body and an animal, can be ingested continuously on a daily basis, has an anti-fatigue activity, and is effective for the prevention or treatment of a disease or condition associated with fatigue. Specifically disclosed is an anti-fatigue agent comprising andrographolide optionally together with an α-lipoic acid as an active ingredient(s). Also disclosed is a novel oral composition comprising andrographolide and an α-lipoic acid. The anti-fatigue agent and the oral composition are useful for the prevention or treatment of chronic fatigue syndrome, overfatigue, physical fatigue, mental fatigue and organ fatigue.06-10-2010
20110118344Novel compound having inhibitory effect on lipase - This invention provides, a novel polyphenol compound having lipase inhibitory activity derived from tealeaves, a process for the preparation of the compound, and foods and/or beverages and pharmaceutical drugs containing the compound.05-19-2011
20120065410ANTI-OBESITY AGENT COMPRISING COMPOUND CONTAINING BENZOTROPOLONE RING - The object of the present invention is to provide an anti-obesity agent which contains a tea-derived component and which is safe and does not compromise the flavor of foods and beverages.03-15-2012

Patent applications by Sumio Asami, Osaka JP

Tadashi Asami, Osaka JP

Patent application numberDescriptionPublished
20100037662ELECTROLYTIC MIST GENERATOR AND WASHING MACHINE USING IT - An electrolytic mist generating device includes electrode parts arranged inside an electrolytic cell, a piezoelectric element that generates mist of electrolytic water, a water supply device that supplies water into the electrolytic cell, a discharging device that discharges the mist generated in the electrolytic cell from an outlet, and a control circuit that controls steps, wherein in an electrolysis step, a voltage that does not permit the mist to be generated is applied to the piezoelectric element to generate a water column.02-18-2010
20100050704ELECTROLYTIC MIST GENERATOR AND WASHING MACHINE USING THE SAME - An electrolytic mist generating device includes electrode parts arranged inside an electrolytic cell, a piezoelectric element that generates mist of electrolytic water, a water supply device that supplies water into the electrolytic cell, and a blowing fan that discharges the mist generated in the electrolytic cell from a mist outlet, so that both production of the electrolytic water and mist generation of the electrolytic water are performed in the electrolytic cell.03-04-2010

Tomonobu Asami, Osaka JP

Patent application numberDescriptionPublished
20120119977DISPLAY DEVICE - A display device has liquid crystal display panels aligned in a horizontal scan direction. The liquid crystal display panels constitute one virtual display area. A decoder decodes image data, to thereby generate pieces of pixel data having addressees corresponding to the virtual display area. A bridge circuit specifies a target (display destination) on which the pixel data is to be displayed on the basis of a parameter table indicating a correspondence between the virtual display area and each of display areas of the liquid crystal display panels. The pixel data are stored in line buffers corresponding to the specified display destinations and outputted to the liquid crystal display panels. Out of the pixel data, pixel data corresponding to a gap formed between two liquid crystal display panels are discarded.05-17-2012